missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Doxorubicin Hydrochloride, Fisher BioReagents
Description
Doxorubicin Hydrochloride
Doxorubicin HCL is a chemotherapeutic agent. Antitumor, immunosuppressive, and antibiotic agent. It blocks RNA polymerase and reverse transcriptase. Also inhibits nucleic acid synthesis.
Specifications
Specifications
| Decomposition Information | 216°C |
| Melting Point | 216°C |
| Color | Orange |
| Assay Percent Range | (by HPLC): ≥95% |
| Packaging | Amber Glass |
| Quantity | 5 mg |
| Merck Index | 15, 3487 |
| Solubility Information | Soluble in water |
| Formula Weight | 580 |
| Physical Form | Powder or Solid |
| Show More |
Safety and Handling
Product Identifier
- Doxorubicin hydrochloride
- Danger
- Acute toxicity Category 4
- Carcinogenicity Category 1B
- Serious eye damage/eye irritation Category 1
- Germ cell mutagenicity Category 1B
- Reproductive toxicity Category 2
- Skin corrosion/irritation Category 2
- Specific target organ toxicity Category 3
- H318-Causes serious eye damage.
- H340-May cause genetic defects.
- H350-May cause cancer.
- H315-Causes skin irritation.
- H361fd-Suspected of damaging fertility. Suspected of damaging the unborn child.
- H335-May cause respiratory irritation.
- H302-Harmful if swallowed.
- P201-Obtain special instructions before use.
- P280-Wear protective gloves/protective clothing/eye protection/face protection.
- P303+P361+P353-IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water/ shower.
- P305+P351+P338-IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
- P310-Immediately call a POISON CENTER/doctor/.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?